Results 251 to 260 of about 297,289 (305)

A six-year longitudinal study identifies a statin-independent association between low LDL-cholesterol and risk of type 2 diabetes. [PDF]

Cardiovasc Diabetol
Lembo M, Trimarco V, Pacella D, Izzo R, Jankauskas SS, Piccinocchi R, Gallo P, Bardi L, Piccinocchi G, Morisco C, Cristiano S, Esposito G, Giugliano G, Manzi MV, Santulli G, Trimarco B.   +15 more
europepmc   +1 more source

Time in LDL cholesterol target range and major adverse cardiovascular events risk: A pooled analysis of two cohorts. [PDF]

Am J Prev Cardiol
Liu Y, Lv Z, Yan H, Liu Y, Zhang J, Bian W, Liu Y, Song Z, Han P, Chen T, Li C.   +10 more
europepmc   +1 more source

Machine learning-based prediction of LDL cholesterol: performance evaluation and validation. [PDF]

PeerJ
Meng JB, An ZJ, Jiang CS.
europepmc   +1 more source

Cholesterol LDL-C

, 2021
openaire   +3 more sources

Remnant cholesterol, not LDL cholesterol, is associated with the risk of hypertension in the middle-aged and elderly population: Bushehr Elderly Health cohort. [PDF]

Front Cardiovasc Med
Esmaeili B, Esmaeili S, Fahimfar N, Rezaei Tavirani M, Razi F, Nabipour I, Khashayar P, Bandarian F.   +7 more
europepmc   +1 more source

What is ‘LDL cholesterol’?

Nature Reviews Cardiology, 2019
LDL cholesterol is an important contributor to the risk of coronary heart disease, and its measurement is central to evaluating the effects of lipid-modifying therapies. Several ‘LDL-cholesterol’ assays exist but their methodologies differ, leading to between-assay heterogeneity in values of ‘LDL cholesterol’.
Michael V. Holmes, Mika Ala-Korpela
openaire   +4 more sources